Skip to Main Content

A medical watchdog group is calling on the National Institutes of Health to immediately stop the enrollment of patients in a clinical trial of sepsis treatment and launch an investigation of how the study received approval, arguing that it puts patients at risk of serious harm, including death.

The group, Public Citizen, says in a letter dated Tuesday that the study’s protocol is also so “fundamentally flawed” that it will not produce reliable findings.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • this trial will not be helpful its plainly intuitive to an intensivist treating a septic pt fluids and if they dont work pressors – the goal is to maintain a MAP >65 and individulailize tx – ie back off fluid if your pt has CHf or CMO so as to not put them in pulm edema. No trial will authoritatively be able to say which path is better.

Comments are closed.